BILEVIA-300

BILEVIA-300 is a hepatoprotective and choleretic agent containing Ursodeoxycholic Acid (UDCA), a naturally occurring bile acid.

It is used to dissolve cholesterol gallstones, improve bile flow, and protect liver cells from injury caused by bile acid toxicity and other hepatic disorders.

UDCA helps restore normal liver function, making BILEVIA-300 an effective treatment for cholestatic liver diseases and gallbladder disorders.

Components

Ursodeoxycholic Acid (UDCA) — 300 mg

Therapeutic Category

Hepatoprotective / Choleretic Agent

Bile Acid Derivative

Benefits

Benefits Dissolves cholesterol gallstones without the need for surgery

Benefits Protects liver cells from bile acid–induced toxicity

Benefits Improves bile secretion and liver enzyme profile

Benefits Reduces cholestasis and associated itching (pruritus)

Benefits Enhances liver detoxification and regeneration

Indications (Uses)

BILEVIA-300 is indicated for the treatment and management of:

Usage Gallstones (cholesterol gallstones)in patients with a functioning gallbladder

Usage Primary biliary cholangitis (PBC)

Usage Cholestatic liver diseases(impaired bile flow)

Usage Non-alcoholic fatty liver disease (NAFLD)— supportive therapy

Usage Drug- or toxin-induced liver damage

Usage Post-operative or chronic liver dysfunction

Usage Cystic fibrosis-related cholestasis (as prescribed)